Literature DB >> 22081608

Identification of novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease.

Mikko Airavaara1, Olga Pletnikova, Maire E Doyle, Yong E Zhang, Juan C Troncoso, Qing-Rong Liu.   

Abstract

Primate-specific genes and isoforms could provide insight into human brain diseases. Our bioinformatic analysis revealed that there are possibly five isoforms of human GDNF gene with different pre- and pro-regions by inter- and intra-exon splicing. By using TaqMan primer probe sets, designed between exons, we verified the expression of all isoforms. Furthermore, a novel GDNFOS gene was found to be transcribed from the opposite strand of GDNF gene. GDNFOS gene has four exons that are spliced into different isoforms. GDNFOS1 and GDNFOS2 are long noncoding RNAs, and GDNFOS3 encodes a protein of 105 amino acids. To study human GDNF and GDNFOS regulation in neurodegenerative diseases, the protein and mRNA levels were measured by Western blot and RT-quantitative PCR, respectively, in postmortem middle temporal gyrus (MTG) of Alzheimer disease (AD) and Huntington disease (HD) patients in comparison with those of normal controls. In the MTG of AD patients, the mature GDNF peptide was down-regulated; however, the transcript of GDNF isoform from human exon 2 was up-regulated, whereas that of the conserved isoform from exon 1 remained unchanged in comparison with those of normal controls. In contrast, the mature GDNF peptide and the isoform mRNA levels were not changed in the MTG of HD. The findings of novel GDNF and GDNFOS isoforms and differences in tissue expression patterns dysregulated in AD brains may further reveal the role of endogenous GDNF in human brain diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081608      PMCID: PMC3247946          DOI: 10.1074/jbc.M111.310250

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Evolution's cauldron: duplication, deletion, and rearrangement in the mouse and human genomes.

Authors:  W James Kent; Robert Baertsch; Angie Hinrichs; Webb Miller; David Haussler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

2.  Aligning multiple genomic sequences with the threaded blockset aligner.

Authors:  Mathieu Blanchette; W James Kent; Cathy Riemer; Laura Elnitski; Arian F A Smit; Krishna M Roskin; Robert Baertsch; Kate Rosenbloom; Hiram Clawson; Eric D Green; David Haussler; Webb Miller
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

3.  GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo.

Authors:  E Arenas; M Trupp; P Akerud; C F Ibáñez
Journal:  Neuron       Date:  1995-12       Impact factor: 17.173

4.  Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.

Authors:  S Hunot; V Bernard; B Faucheux; F Boissière; E Leguern; C Brana; P P Gautris; J Guérin; B Bloch; Y Agid; E C Hirsch
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

5.  Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor.

Authors:  L R Williams; G Inouye; V Cummins; M A Pelleymounter
Journal:  J Pharmacol Exp Ther       Date:  1996-05       Impact factor: 4.030

6.  Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex.

Authors:  Y Wang; S Z Lin; A L Chiou; L R Williams; B J Hoffer
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

7.  Cloning and structural organization of the gene encoding the mouse glial cell line-derived neurotrophic factor, GDNF.

Authors:  N Matsushita; Y Fujita; M Tanaka; T Nagatsu; K Kiuchi
Journal:  Gene       Date:  1997-12-12       Impact factor: 3.688

8.  GDNF is expressed in two forms in many tissues outside the CNS.

Authors:  C Suter-Crazzolara; K Unsicker
Journal:  Neuroreport       Date:  1994-12-20       Impact factor: 1.837

9.  Glial cell line-derived neurotrophic factor enhances survival and growth of prenatal and postnatal spinal cord transplants.

Authors:  K Trok; B Hoffer; L Olson
Journal:  Neuroscience       Date:  1996-03       Impact factor: 3.590

10.  GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle.

Authors:  C E Henderson; H S Phillips; R A Pollock; A M Davies; C Lemeulle; M Armanini; L Simmons; B Moffet; R A Vandlen; L Simpson LC corrected to Simmons; V E Koliatsos; A Rosenthal
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

View more
  47 in total

Review 1.  The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease.

Authors:  Josiane Budni; Tatiani Bellettini-Santos; Francielle Mina; Michelle Lima Garcez; Alexandra Ioppi Zugno
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 2.  Long noncoding RNA and its contribution to autism spectrum disorders.

Authors:  Jie Tang; Yizhen Yu; Wei Yang
Journal:  CNS Neurosci Ther       Date:  2017-06-20       Impact factor: 5.243

Review 3.  The Role of Long Noncoding RNAs in Neurodegenerative Diseases.

Authors:  Peixing Wan; Wenru Su; Yehong Zhuo
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

Review 4.  Invited Review: Long non-coding RNAs: important regulators in the development, function and disorders of the central nervous system.

Authors:  R Cuevas-Diaz Duran; H Wei; D H Kim; J Q Wu
Journal:  Neuropathol Appl Neurobiol       Date:  2019-03-04       Impact factor: 8.090

5.  Availability of Pre- and Pro-regions of Transgenic GDNF Affects the Ability to Induce Axonal Sprout Growth.

Authors:  Nadezda Kust; Dmitri Panteleev; Ilya Mertsalov; Ekaterina Savchenko; Ekaterina Rybalkina; Alexander Revishchin; Galina Pavlova
Journal:  Mol Neurobiol       Date:  2014-07-03       Impact factor: 5.590

6.  Lenti-GDNF gene therapy protects against Alzheimer's disease-like neuropathology in 3xTg-AD mice and MC65 cells.

Authors:  Susana Revilla; Suzanna Ursulet; María Jesús Álvarez-López; Marco Castro-Freire; Unai Perpiñá; Yoelvis García-Mesa; Analía Bortolozzi; Lydia Giménez-Llort; Perla Kaliman; Rosa Cristòfol; Chamsy Sarkis; Coral Sanfeliu
Journal:  CNS Neurosci Ther       Date:  2014-08-13       Impact factor: 5.243

7.  Dominant and Protective Role of the CYTH4 Primate-Specific GTTT-Repeat Longer Alleles Against Neurodegeneration.

Authors:  M Rezazadeh; J Gharesouran; A Movafagh; M Taheri; H Darvish; B Emamalizadeh; N Shahmohammadibeni; H R Khorram Khorshid; M Behmanesh; M A Sahraian; M Ohadi
Journal:  J Mol Neurosci       Date:  2015-04-01       Impact factor: 3.444

8.  Do serum GDNF levels correlate with severity of Alzheimer's disease?

Authors:  Maryam Sharif; Maryam Noroozian; Farshad Hashemian
Journal:  Neurol Sci       Date:  2020-11-19       Impact factor: 3.307

Review 9.  Noncoding RNAs in neurodegeneration.

Authors:  Evgenia Salta; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

Review 10.  Long noncoding RNAs in psychiatric disorders.

Authors:  Lingjun Zuo; Yunlong Tan; Zhiren Wang; Ke-Sheng Wang; Xiangyang Zhang; Xiangning Chen; Chiang-Shan R Li; Tong Wang; Xingguang Luo
Journal:  Psychiatr Genet       Date:  2016-06       Impact factor: 2.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.